<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Gly380 --&gt; Arg mutation in the TM domain of fibroblast growth factor receptor 3 (FGFR3) of the RTK family is linked to <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e>, the most common form of human <z:hpo ids='HP_0003510'>dwarfism</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The molecular mechanism of pathology induction is under debate, and two different mechanisms have been proposed to contribute to pathogenesis: (1) Arg380-mediated FGFR3 dimer stabilization and (2) slow downregulation of the activated mutant receptors </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show that the Gly380 --&gt; Arg mutation does not alter the dimerization energetics of the FGFR3 transmembrane domain in detergent micelles or in <z:chebi fb="23" ids="18059">lipid</z:chebi> bilayers </plain></SENT>
<SENT sid="3" pm="."><plain>This result indicates that pathogenesis in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> cannot be explained simply by a higher dimerization propensity of the mutant FGFR3 TM domain, thus highlighting the importance of the observed slow downregulation in phenotype induction </plain></SENT>
</text></document>